- HK$1.19bn
- HK$58.15m
- CNY1.42bn
- 68
- 96
- 37
- 80
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,416 | 1,282 | 1,377 | 1,530 | 1,417 |
Cost of Revenue | |||||
Gross Profit | 399 | 384 | 404 | 403 | 420 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,208 | 1,112 | 1,221 | 1,358 | 1,245 |
Operating Profit | 208 | 170 | 156 | 173 | 171 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 207 | 169 | 155 | 164 | 174 |
Provision for Income Taxes | |||||
Net Income After Taxes | 176 | 145 | 138 | 161 | 151 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 177 | 146 | 138 | 147 | 132 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 177 | 146 | 138 | 147 | 132 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.212 | 0.175 | 0.168 | 0.181 | 0.168 |
Dividends per Share | |||||
Special Dividends per Share |